Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
JJS
5976
DELISTED
iPath Bloomberg Softs Subindex Total Return ETN due June 24, 2038
JJS
| $12K | ﹤0.01% |
406
+45
| +12% | +$1.43K |
2015 Q4
7 quarters
|
|
|
TORM
5977
DELISTED
TOR Minerals International Inc
TORM
| $12K | ﹤0.01% |
+1,600
| New | +$12.4K |
2017 Q3
0 quarters
|
|
5978
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $12K | ﹤0.01% |
1,066
+1,032
| +3,035% | +$45.8K |
2016 Q1
6 quarters
|
|
|
SDR
5979
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
| $12K | ﹤0.01% |
9,575
-2,075
| -18% | -$2.86K |
2013 Q2
17 quarters
|
|
|
GCVRZ
5980
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $12K | ﹤0.01% |
33,385
-1,304
| -4% | -$483 |
2013 Q2
17 quarters
|
|
5981
DELISTED
Astria Therapeutics
ATXS
| $11K | ﹤0.01% |
87
+6
| +7% | +$500 |
2015 Q3
8 quarters
|
|
5982
DELISTED
Carisma Therapeutics
CARM
| $11K | ﹤0.01% |
350
-15
| -4% | -$419 |
2014 Q1
14 quarters
|
|
5983
Good Times Restaurants
GTIM
$14.8M
| $11K | ﹤0.01% |
4,000
-7,546
| -65% | -$23.3K |
2013 Q4
15 quarters
|
|
5984
Inseego
INSG
$77.2M
| $11K | ﹤0.01% |
795
-677
| -46% | -$8.66K |
2013 Q2
17 quarters
|
|
5985
Landmark Bancorp
LARK
$190M
| $11K | ﹤0.01% |
594
| – | – |
2013 Q4
15 quarters
|
|
5986
Lipocine
LPCN
$13.4M
| $11K | ﹤0.01% |
157
-581
| -79% | -$42K |
2015 Q2
9 quarters
|
|
5987
PAR Technology
PAR
$643M
| $11K | ﹤0.01% |
1,080
-625
| -37% | -$6.02K |
2017 Q2
1 quarter
|
|
5988
TRX Gold Corp
TRX
$380M
| $11K | ﹤0.01% |
35,000
+19,500
| +126% | +$8.14K |
2013 Q2
17 quarters
|
|
5989
DELISTED
Titan Pharmaceuticals
TTNP
| $11K | ﹤0.01% |
2
-8
| -80% | -$49.5K |
2015 Q4
7 quarters
|
|
5990
DELISTED
Village Bank and Trust Financial Corp.
VBFC
| $11K | ﹤0.01% |
320
| – | – |
2013 Q4
15 quarters
|
|
5991
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
| $11K | ﹤0.01% |
3
| – | – |
2017 Q2
1 quarter
|
|
|
RADA
5992
DELISTED
Rada Electronic Industries Ltd
RADA
| $11K | ﹤0.01% |
+3,300
| New | +$8.37K |
2017 Q3
0 quarters
|
|
|
CDTI
5993
DELISTED
CDTI Advanced Materials, Inc. Common Stock
CDTI
| $11K | ﹤0.01% |
1,252
+252
| +25% | +$2.72K |
2017 Q2
1 quarter
|
|
|
OSN
5994
DELISTED
Ossen Innovation Co., Ltd.
OSN
| $11K | ﹤0.01% |
6,800
| – | – |
2017 Q1
2 quarters
|
|
|
SPHS
5995
DELISTED
Sophiris Bio, Inc.
SPHS
| $11K | ﹤0.01% |
5,000
+2,000
| +67% | +$4.14K |
2013 Q4
15 quarters
|
|
5996
Allot
ALLT
$451M
| $10K | ﹤0.01% |
1,813
-6,481
| -78% | -$32.8K |
2013 Q4
15 quarters
|
|
5997
Altimmune
ALT
$506M
| $10K | ﹤0.01% |
135
-34
| -20% | -$2.53K |
2013 Q3
16 quarters
|
|
5998
Bank Of The James
BOTJ
$124M
| $10K | ﹤0.01% |
+760
| New | +$10.3K |
2017 Q3
0 quarters
|
|
5999
Co-Diagnostics
CODX
$7.89M
| $10K | ﹤0.01% |
+51
| New | +$7.79K |
2017 Q3
0 quarters
|
|
6000
DarioHealth
DRIO
$56.3M
| $10K | ﹤0.01% |
+14
| New | +$12.4K |
2017 Q3
0 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.